Entity
  • Elnora AI

    Created in 2023
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,152 1,152
  • Activities

  • Technologies

  • Entity types

  • Location

    Tallinn (EE) - Sankt Petersburg (RU)

    Tallinn

    Estonia

  • Employees

    Scale: 2-10

    Estimated: 8

  • Engaged corporates

    1
    0 1
  • Added in Motherbase

    10 months, 2 weeks ago
Description
  • Value proposition

    Rewriting the rules of antiviral drug discovery using the power of HI+AI.

    Thousands of viruses have the potential to infect humans, but the number of available antiviral drugs can be counted in the tens. The vast diversity of viruses, combined with their rapid mutation rate—as starkly evidenced by the recent Covid-19 pandemic—makes antiviral drug discovery exceptionally challenging.

    At Elnora AI, we stand at the crossroads of artificial intelligence and drug discovery. Our mission is to chart a new course for antiviral drugs by focusing on host cells rather than directly targeting viruses. This innovative approach provides potential resistance to viral mutations and broad-spectrum efficacy against various viral strains. Moreover, it positions us to effectively tackle newly emerging viruses. This strategy, previously almost impossible due to the expansive nature of human genomic data and concerns over potential side effects, is now within our grasp, thanks to the capabilities of AI.

    We are harnessing the power of Elnora, our AI-enabled end-to-end drug discovery platform, to uphold our commitment to global health. Elnora provides scientists with profound insights into disease mechanisms and spotlights high-potential drug candidates. What sets Elnora apart is its ability to seamlessly integrate data from diverse sources from drug databases and scientific literature to omics data, present it coherently and factually, and propose entirely novel concepts. By integrating AI into our antiviral drug discovery, we're not only accelerating the research process by years but also reducing costs by hundreds of millions. We're optimistic that this strategy will lead to orally available small molecules with a higher probability of clinical success.

    With Elnora AI, the future of antiviral treatments isn't merely promising—it's transformative.


    Artificial Intelligence, Drug Development, Antiviral Drugs, Pharmaceutical, BioPharma, Drug Discovery, AI Drug Discovery, DeepTech, HealthTech, Technology, and TechBio

  • Nora AI - Antiviral Drug-Discovery Start-Up

    Nora is an Estonian based AI start-up that transforms antiviral drug discovery. Nora AI targets host cells, not viruses directly, providing resistance to mutations and broad efficacy. This readies us for future pandemics, also fast-tracks research, reduces costs, and amplifies chances of clinical success.

  • https://www.elnora.ai/
Corporate interactions BETA
Corporate TypeTweets Articles
EU-Startups
EU-Startups
Media, Software Development
EU-Startups
Media, Software Development
Other

30 Apr 2024


Similar entities
Loading...
Loading...
Social network dynamics